Hyperthyroidism with increased factor VIII procoagulant protein as a predisposing factor for cerebral venous thrombosis [3]

Journal of Neurology Neurosurgery and Psychiatry

Volumn 73, Issue 4, 2002, Pages 458-

  Maes, J ^a   Michotte, A ^a   Velkeniers, B ^a   Stadnik, T ^a   Jochmans, K ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 8; HEPARIN;

ADULT; ANTICOAGULANT THERAPY; AUTOIMMUNE DISEASE; BLOOD CLOTTING DISORDER; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; FEMALE; HEPARINIZATION; HUMAN; HYPERTHYROIDISM; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PHLEBOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0036786828     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.73.4.458     Document Type: Letter

References (5)

1. Ameri A, Bousser M. Cerebral venous thrombosis. Neurol Clin 1992;10:87-111.
2. Einhaüpl K, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991;338:597-600.
3. Simone J, Abildgaard C, Schulman I. Blood coagulation in thyroid dysfunction. N Engl J Med 1965;273:1057-61.
4. Koster T, Blann A, Briët E, et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-5.
5. Verberne H, Fliers E, Prummel M, et al. Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis. Thyroid 2000;10:607-61.